QUAVONLIMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:40:10 GMT 2023` Edited by `admin` on `Sat Dec 16 13:40:10 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	GG0AN49Y59
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

QUAVONLIMAB

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER

Common Name

English

quavonlimab [INN]

Common Name

English

QUAVONLIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV3-72*01 (84.7%)-(IGHD)-IGHJ4*01 (92.9%)) CDR-IMGT (8.10.6)

Common Name

English

Quavonlimab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

MK-1308A COMPONENT QUAVONLIMAB

Code

English

Code System Code Type Description

CLINICAL_TRIALS.GOV

NCT03179436